THE-0504 in Patients With Solid Tumors

Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.

Trial Details

NCT ID
NCT07646106
Phase
PHASE1
Sponsor
Thena Biotech S.r.l.
Status
RECRUITING
Cancer Type
Adenocarcinoma Lung Cancer
Interventions
  • THE-0504
Locations (sample)
  • Rome, Lazio, Italy|41.89193,12.51133

Key Eligibility Criteria

  • Patients will be enrolled in the study if they meet all the following criteria:
  • written informed consent obtained;
  • both gender adult (≥ 18 years) patients;
  • diagnosis of solid tumor. Preferably, but non-limited, tumor types are the following: Small Cell Lung Cancer (SCLC), Colorectal Carcinoma (CRC), Pa…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Adenocarcinoma Lung Cancer Trials on Trialify →